[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"peri-implant-health\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:peri-implant-health":64},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,8,0,[8,48,77,102,131,167,195,219],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":29,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":47},"100616372","effect-of-probe-material-on-peri-implant-probing-100616372",false,"NCT07304752","Effect of Probe Material on Peri-implant Probing","Effect of Probe Material (Metallic vs. Plastic) on Peri-implant Probing: a Randomized Clinical Trial.","METPLA-PP","Inclusion Criteria:\n\n* Adults (≥18 years)\n* Presence of at least one single-unit bone-level implant rehabilitated with a screw-retained prosthesis directly connected to the implant (no intermediate abutment)\n* Implant in function for at least 1 year after prosthetic loading\n* No pathological bone loss on periapical radiograph (distance from the most coronal rough surface of the implant to the bone crest \\\u003C 3 mm)\n* Ability to understand and sign informed consent\n* Peri-implant health or mucositis, defined according to the 2017 World Workshop criteria:\n* Health: no clinical signs of inflammation, lack of profuse (line or drop) bleeding on probing, no increase in probing depth compared to previous records, and no progressive bone loss beyond initial remodeling (\\\u003C2 mm). In the absence of previous radiographs, radiographic bone level \\\u003C3 mm without bleeding and\u002For suppuration on probing.\n* Mucositis: presence of bleeding and\u002For suppuration on probing, no increase in probing depth compared to previous records, and no bone loss beyond initial remodeling (\\\u003C2 mm). In the absence of previous radiographs, radiographic bone level \\\u003C3 mm with bleeding and\u002For suppuration on probing.\n\nExclusion Criteria:\n\n* Cement-retained restorations or prostheses that cannot be removed\n* Systemic antibiotic or anti-inflammatory treatment within the previous 3 months\n* Pregnancy or lactation\n* Peri-implant treatment within the previous 3 months\n* Participation in another clinical trial within the last 30 days","ALL","18 Years",{"count":20,"type":21},64,"ESTIMATED","INTERVENTIONAL",[24],"NA","Evaluate whether the type of probe (plastic vs. metallic) modifies the accuracy of peri-implant probing in single-unit implants, by comparing the probing depth recorded with the prosthesis in place versus without the prosthesis (ΔPD, mm). Secondarily, explore the influence of prosthetic design and implant position on probing values and on other clinical and radiographic parameters.",[27,28],"Peri-implant Health","Peri-implant Mucositis",[30,31,32,33,34],"Visual Analogue Scale","Peri-implant probing","Probing depth","Emergency profile","Dental implant","RECRUITING","2026-06-21",{"date":38,"type":39},"2026-06-24","ACTUAL",{"date":41,"type":39},"2026-01-01",{"date":43,"type":21},"2026-10",{"name":45,"class":46},"University of Barcelona","OTHER",1,{"id":49,"slug":50,"hasResults":11,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":4,"eligibilityCriteria":54,"healthyVolunteers":55,"sex":17,"minAge":56,"maxAge":57,"enrollmentInfo":58,"targetDuration":4,"studyType":22,"phases":60,"briefSummary":61,"conditions":62,"keywords":4,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":47},"100641906","evaluation-of-multilayered-prf-in-comparison-with-connective-tissue-graft-by-sohn-ponchos-technique-on-peri-implant-mucosal-enhancement-in-the-esthetic-zone-100641906","NCT07649239","Evaluation of Multilayered PRF in Comparison With Connective Tissue Graft by Sohn Poncho's Technique on Peri-implant Mucosal Enhancement in the Esthetic Zone","Evaluation of Multilayered PRF in Comparison With Connective Tissue Graft by Sohn Poncho's Technique on Peri-implant Mucosal Enhancement in the Esthetic Zone. A Randomized Clinical Trial","-Inclusion Criteria: Patients with single bounded missing tooth in the esthetic zone Patients in the age group of 21-65 years Patients having good oral hygiene (mean plaque score of \\\u003C 25%) and with stable periodontal status.\n\n-Exclusion Criteria: Smokers patients Patients with poor maintenance of oral hygiene, as determined by a mean plaque score of ≥ 25% despite efforts by the clinician to improve oral hygiene maintenance.\n\nPatients with medically compromised conditions like uncontrolled diabetes mellitus or any systemic diseases that may result in compromised hard and soft tissue healing.",true,"20 Years","70 Years",{"count":59,"type":21},26,[24],"An effective biological seal is crucial for protecting and supporting dental implants, particularly in the anterior region for the desired esthetic outcome.PRF membrane and CTG has been utilized to improve peri-implant soft tissue thickness and increase the width of keratinized tissue around dental implants. The stability of the PRF membrane is maintained by securing it with the healing abutment of the implant. While a few longitudinal studies have assessed the benefits of using PRF membrane with Sohn's Poncho technique in the posterior region, its effectiveness in the anterior region of the mouth remains to be evaluated.",[63,64,65,66,67],"Soft Tissue","Peri-Implant Health","Soft Tissue Augmentation at Dental Implants","Connective Tissue Graft","PRF","2026-06-12",{"date":70,"type":39},"2026-06-16",{"date":72,"type":39},"2026-01-10",{"date":74,"type":21},"2027-02-01",{"name":76,"class":46},"Gulf Medical University",{"id":78,"slug":79,"hasResults":11,"nctId":80,"briefTitle":81,"officialTitle":81,"acronym":82,"eligibilityCriteria":83,"healthyVolunteers":55,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":84,"targetDuration":4,"studyType":22,"phases":86,"briefSummary":87,"conditions":88,"keywords":90,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":96,"completionDateStruct":98,"leadSponsor":100,"locationsCount":47},"100638282","volumetric-analysis-of-peri-implant-soft-tissue-changes-between-polyethereketonepeek-anatomic-healing-abutments-and-standard-healing-abutments-in-posterior-single-implant-restorations-100638282","NCT07624331","Volumetric Analysis of Peri-Implant Soft Tissue Changes Between Polyethereketone(PEEK) Anatomic Healing Abutments and Standard Healing Abutments in Posterior Single Implant Restorations","anatomic","Inclusion Criteria:\n\nlegally competent to provide written informed consent form prior to any study related procedures.\n\n* Subjects of either sex or aged 18 above\n* requires replacement of a single missing posterior tooth with adequate mesiodistal dimension (≥8 mm)\n* intact adjacent teeth on both sides with existing opposing tooth condition\n* good oral hygiene, plaque score \\\u003C25% bpe1\n* adequate keratinized mucosa width (kmw) minimum 6 mm at the edentulous site\n* adequate bone volume to accommodate the planned dental implant placement of 5.5 mm diameter and 10 mm in length as verifified by Cone Beam Computed Tomography (CBCT)\n* adequate interoccusal distance (crown height space) of at least 6mm measured from alveolar crest to the occlusal table.\n\nExclusion Criteria:\n\nLocalized or generalized periodontitis\n\n* Presence of active acute infection\n* History of malignancy, radiotherapy or chemotherapy\n* Bone metabolic diseases (e.g.: osteogenesis imperfecta, Paget's disease) or current use of medications affecting bone metabolism\n* Untreated bruxism or parafunctional habits Docusign Envelope ID: FFD7C6C1-66CB-4359-9662-63230F769528 22\n* Severe occlusal discrepancy\n* Any medical condition contraindicating implant placement or alter daily activities to a level consistent with ASA (American Society of Anesthesiologist) III classification (including cardiovascular, hepatic, renal, gastrointestinal, metabolic, neurologic, pulmonary, endocrine, autoimmune or psychiatric disorders)\n* Subjects in need of bone grafting at the site of intended implantation site.\n* Subjects that are pregnant",{"count":85,"type":21},38,[24],"This prospective randomized clinical trial will evaluate the clinical outcomes of the implant crown fabricated with standard scan body (control) and polyetheretherketone (PEEK) anatomic healing abutment (test).",[64,89,65],"Peri-Implant Tissues",[89,91,92],"volumetric analysis","soft tissue","2026-05-31",{"date":95,"type":39},"2026-06-03",{"date":97,"type":21},"2026-05-23",{"date":99,"type":21},"2028-10-01",{"name":101,"class":46},"DR NUR HAFIZAH KAMAR AFFENDI",{"id":103,"slug":104,"hasResults":11,"nctId":105,"briefTitle":106,"officialTitle":107,"acronym":4,"eligibilityCriteria":108,"healthyVolunteers":55,"sex":17,"minAge":18,"maxAge":109,"enrollmentInfo":110,"targetDuration":4,"studyType":22,"phases":112,"briefSummary":113,"conditions":114,"keywords":116,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":122,"lastUpdatePostDateStruct":123,"startDateStruct":125,"completionDateStruct":127,"leadSponsor":129,"locationsCount":47},"100508400","comparison-of-the-effectiveness-of-two-different-surgical-therapeutic-protocols-of-peri-implantitis-100508400","NCT05899933","Comparison of the Effectiveness of Two Different Surgical Therapeutic Protocols of Peri-implantitis","Implantoplasty Versus Implant Decontamination With Erythritol Air-abrasive Device During Surgical Therapy of Peri-implantitis. Clinical, Radiographic and Microbiological Evaluation. A Randomized Controlled Clinical Study","Inclusion Criteria:\n\nGeneral Inclusion Criteria:\n\n* Participants ≥ 18 years and ≤ 80 years of age\n* Non-smokers based on the patients' self-reported smoking status, defined as patients who had never smoked or had quit smoking at least 2 years ago\n* Implants in function for more than 1 year after suprastructure connection\n\nInclusion Criteria for implants diagnosed with Peri-Implantitis:\n\n* Presence of at least one implant diagnosed with peri-implantitis defined as presence of bleeding on probing and\u002For suppuration, probing pocket depth ≥6 mm and ≥3 mm of detectable bone loss after initial re-modelling\n* Absence of implant mobility\n\n  * in participants with more than one implant, the implant with the worst clinical condition will be studied.\n\nInclusion Criteria for implants diagnosed with Peri-Implant Health:\n\n* Absence of peri-implant signs of inflammation (redness, swelling)\n* Lack of bleeding on probing\n* Absence of bone loss beyond crestal bone level changes resulting from initial remodeling, which should not be ≥2 mm\n\nExclusion Criteria:\n\n* Smokers\n* Uncontrolled diabetes mellitus (HBA1c \\>7)\n* Treatment with bisphosphonates\n* Needing antibiotic prophylaxis\n* Currently pregnant or breast-feeding women\n* History of systemic administration of antibiotic treatment during the preceding 3 months\n* Systemic conditions that contraindicate treatment\n* Use of medications known to induce gingival hyperplasia","80 Years",{"count":111,"type":21},45,[24],"The purpose of the present study is to compare the 1-year clinical, radiographic and microbiological outcomes and patients' satisfaction following surgical treatment of peri-implantitis after applying two different surface modification methods. Secondarily, analysis and comparison of the microbiological results of implants diagnosed and treated for peri-implantitis with healthy implants will be performed.",[115,64],"Peri-Implantitis",[115,117,118,119,120,121],"Surgical therapy","Implantoplasty","Air-abrasive device","Erythritol powder","Peri-Implant microbiota","2026-04-14",{"date":124,"type":39},"2026-04-15",{"date":126,"type":39},"2023-07-28",{"date":128,"type":21},"2026-12",{"name":130,"class":46},"National and Kapodistrian University of Athens",{"id":132,"slug":133,"hasResults":11,"nctId":134,"briefTitle":135,"officialTitle":135,"acronym":4,"eligibilityCriteria":136,"healthyVolunteers":55,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":137,"targetDuration":4,"studyType":139,"phases":4,"briefSummary":140,"conditions":141,"keywords":149,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":158,"lastUpdatePostDateStruct":159,"startDateStruct":161,"completionDateStruct":163,"leadSponsor":165,"locationsCount":47},"100633411","digital-planning-and-clinical-assessment-of-the-treated-atrophic-posterior-maxilla-with-a-sinus-lift-procedure-a-cross-sectional-study-100633411","NCT07526337","Digital Planning and Clinical Assessment of the Treated Atrophic Posterior Maxilla With a Sinus Lift Procedure: a Cross-sectional Study.","Inclusion Criteria:\n\n* \\- Patient aged more than 18 years.\n* Partially edentulous patients having an implant rehabilitation treated with a sinus lift procedure in the atrophic posterior maxilla.\n* Patient with no systemic disease that contraindicate the surgical procedure as uncontrolled diabetes mellitus, bleeding disorders, recent myocardial infarction, head and neck radiation, and mental disorders.\n\nExclusion Criteria:\n\n* \\- Fully Edentulous patients.\n* Patients presenting sinus pathologies (sinusitis, thickening of the membrane).\n* Patient smoking more than 20 cigarettes.\n* Patient taking systemic drugs that could affect bone healing as immune suppressive drugs and bisphosphonates.\n* Patient with systemic disease that contraindicate the surgical procedure as uncontrolled diabetes mellitus, bleeding disorders, recent myocardial infarction, head and neck radiation, and mental disorders.",{"count":138,"type":21},100,"OBSERVATIONAL","Maxillary posterior area is the most challenging site for dental implant placement. Indeed, complex remodeling processes, resulting in changes of the maxillary sinus and shape of the alveolar ridge will cause difficulties in rehabilitating the posterior maxillae sites. Various techniques have been proposed in order to achieve the necessary bone volume for the placement of long term successful implants. However, unbalanced crown to implant ratio remains a risk factor after successful dental implants installation following sinus graft. No study on humans assessed the effect of apical positioning of the implants in posterior grafted sites (sinus graft or sinus graft + vertical GBR) on the following clinical parameters: The peri-implant bone remodeling (vertical bone loss (mm) and probing depth (mm) around the implants, crown bulkiness, emergence profile and crown height, and Patients satisfaction, food impaction (PROM)).\n\nThis study will elucidate these points and based on the parameter's results, suggest a treatment based classification facilitating the treatment decision-making of the clinicians in case of an atrophic posterior maxilla; aiming to ensure a long-term successful supra-implant rehabilitation which will maintain its bio-mechanically and biological success.",[142,143,64,144,145,146,147,148],"Alveolar Bone Atrophy","Alveolar Bone Grafting","Sinus Floor Augmentation","Vertical Ridge Deficiency","Guided Bone Regeneration","Digital Guided Bone Regeneration","Prosthetic Complication",[150,151,152,153,154,155,156,157],"alveolar bone atrophy","digital planning","guided bone regeneration","maxillary sinus","peri-implant disease","peri-implantits","sinus floor augmentation","vertical ridge deficiency","2026-04-06",{"date":160,"type":39},"2026-04-13",{"date":162,"type":39},"2025-01-01",{"date":164,"type":21},"2026-05-30",{"name":166,"class":46},"Saint-Joseph University",{"id":168,"slug":169,"hasResults":11,"nctId":170,"briefTitle":171,"officialTitle":172,"acronym":4,"eligibilityCriteria":173,"healthyVolunteers":55,"sex":17,"minAge":18,"maxAge":57,"enrollmentInfo":174,"targetDuration":4,"studyType":22,"phases":176,"briefSummary":177,"conditions":178,"keywords":181,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":186,"lastUpdatePostDateStruct":187,"startDateStruct":189,"completionDateStruct":191,"leadSponsor":193,"locationsCount":47},"100628017","influence-of-zirconia-abutments-on-peri-implant-tissues-in-single-tooth-restorations-100628017","NCT07456163","Influence of Zirconia Abutments on Peri-Implant Tissues in Single-Tooth Restorations","Potential Influence of Pre-fabricated and Customized Anatomical Zirconia Abutments in the Peri-implant Region for Single-tooth Implant-supported Prosthetic Restorations","Inclusion Criteria:\n\n1. Individuals aged 18 years or older;\n2. Participants in the Master's Thesis entitled: \"Dimensional Changes Following Different Alveolar Preservation Protocols in Posterior Regions: A Randomized Controlled Study\";\n3. Patients with implants and healing abutments from Bionnovation Biomedical in place at the time of prosthetic rehabilitation;\n4. Implants without surrounding bone loss;\n5. Signed informed consent form.\n\nExclusion Criteria:\n\n1. Patients with uncontrolled systemic diseases;\n2. Pregnant or lactating women;\n3. Smokers or former smokers;\n4. Undergoing orthodontic treatment;\n5. Using medications that interfere with bone healing, such as those for osteoporosis and bisphosphonates;\n6. Implants with bone loss or failed implants.",{"count":175,"type":21},71,[24],"Objectives:\n\nTo compare the influence of pre-fabricated titanium abutments and customized milled zirconia abutments on implant biocompatibility and the peri-implant region, as well as on radiographic bone loss and oral health-related quality of life.\n\nDetailed Methodology:\n\nThis study is a randomized controlled clinical trial designed to evaluate the biological and clinical behavior of standardized titanium abutments compared with customized anatomical zirconia abutments in single implant-supported posterior restorations. The present investigation represents the prosthetic phase of a previously conducted randomized clinical trial that evaluated dimensional changes following different alveolar preservation protocols in posterior regions (CAAE: 59208422.8.0000.5418). In the previous phase, participants underwent tooth extraction and alveolar preservation procedures, followed by implant placement with Morse Taper (CM) implants (Biomorse XP, Bionnovation Biomedical) after a six-month healing period. After implant osseointegration, participants eligible for prosthetic rehabilitation will be randomly allocated to one of two parallel groups using a computer-generated randomization sequence (Sealedenvelope.com). The allocation ratio will be 1:1. Sample size calculation was performed using GPower software to ensure adequate statistical power. The intervention consists of prosthetic rehabilitation with either standardized titanium abutments (TiB group) or customized anatomical zirconia abutments (ZiT group), both supporting single zirconia crowns in posterior regions. All prosthetic and laboratory procedures will follow standardized clinical protocols. Clinical and laboratory assessments will be conducted at prosthesis delivery (baseline) and at 1-, 3-, 6-, and 12-month follow-up visits. Data collection will include peri-implant crevicular fluid (PICF) and biofilm sampling for biomolecular analysis, comprehensive periodontal clinical parameters, measurement of keratinized mucosa thickness, standardized periapical radiographs for marginal bone level assessment, and intraoral digital scanning for volumetric and soft tissue analysis. The primary objective is to compare peri-implant tissue stability and biological response between titanium and zirconia abutments. Secondary outcomes include clinical parameters, marginal bone level changes, and soft tissue dimensional stability over a 12-month follow-up period. This study aims to contribute to the understanding of how abutment material and design may influence peri-implant health and long-term tissue stability in posterior implant-supported restorations.",[64,179,180],"Implant Complication","Prosthesis and Implants",[182,183,184,185],"Dental Prosthesis","Connection, Dental Implant-Abutment","Dental Porcelain","Biofilm","2026-03-13",{"date":188,"type":39},"2026-03-17",{"date":190,"type":39},"2025-04-30",{"date":192,"type":21},"2027-12-01",{"name":194,"class":46},"University of Campinas, Brazil",{"id":196,"slug":197,"hasResults":11,"nctId":198,"briefTitle":199,"officialTitle":200,"acronym":4,"eligibilityCriteria":201,"healthyVolunteers":11,"sex":17,"minAge":202,"maxAge":4,"enrollmentInfo":203,"targetDuration":4,"studyType":22,"phases":205,"briefSummary":206,"conditions":207,"keywords":4,"overallStatus":209,"whyStopped":4,"lastUpdateSubmitDate":210,"lastUpdatePostDateStruct":211,"startDateStruct":213,"completionDateStruct":215,"leadSponsor":217,"locationsCount":47},"100618360","clinical-radiographic-and-digital-evaluation-of-the-effects-of-autogenous-grafts-on-peri-implant-mucosa-100618360","NCT07330609","Clinical, Radiographic, and Digital Evaluation of the Effects of Autogenous Grafts on Peri-implant Mucosa","Clinical, Radiographic, and Digital Evaluation of the Effects of Autogenous Grafts Harvested From Different Palatal Sites and Applied During Second-stage Implant Surgery on the Peri-implant Mucosa","Inclusion Criteria:\n\n* Age over 18 years\n* Systemically healthy patients\n* Presence of premolar or molar tooth loss in the mandible\n* Adequate mesiodistal and interocclusal space for implant and restoration placement\n* At least four months elapsed since tooth extraction\n* Alveolar bone width of at least 6 mm and sufficient alveolar bone height to allow implant placement without compromising anatomical structures\n* Full-mouth plaque and bleeding scores less than 20%\n* Presence of opposing teeth in occlusion\n* Keratinized mucosa width in the relevant region less than 2 mm\n* Keratinized mucosa thickness in the relevant region of 2 mm or less\n* Presence of a healthy second premolar in the maxilla\n* Provision of written informed consent and permission for the use of data for research purposes\n\nExclusion Criteria:\n\n* Poor oral hygiene\n* Uncontrolled periodontal disease\n* Pregnancy or lactation at any stage of the study\n* Uncontrolled diabetes mellitus\n* Immunocompromised patients\n* Previous radiotherapy to the head and neck region\n* Diseases or medications affecting bone metabolism\n* Antibiotic use within the three months prior to the procedure\n* Smoking more than 10 cigarettes per day\n* Pre- or simultaneous bone augmentation prior to implant placement\n* Lack of primary stability at the time of implant placement","18 Months",{"count":204,"type":21},30,[24],"This study aims to evaluate the effects of autogenous grafts harvested from different palatal regions on the peri-implant mucosa when applied during second-stage dental implant surgery.\n\nClinical, radiographic, and digital assessment methods will be used to investigate the early effects of these grafts on peri-implant mucosal width and thickness. In addition, peri-implant tissue health and patient-reported outcomes will be evaluated to compare the effectiveness of the grafting techniques in peri-implant soft tissue management.",[27,208,28],"Free Gingival Graft","NOT_YET_RECRUITING","2025-12-29",{"date":212,"type":39},"2026-01-09",{"date":214,"type":21},"2026-02-02",{"date":216,"type":21},"2027-11-01",{"name":218,"class":46},"Kutahya Health Sciences University",{"id":220,"slug":221,"hasResults":11,"nctId":222,"briefTitle":223,"officialTitle":224,"acronym":225,"eligibilityCriteria":226,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":227,"targetDuration":229,"studyType":139,"phases":4,"briefSummary":230,"conditions":231,"keywords":235,"overallStatus":209,"whyStopped":4,"lastUpdateSubmitDate":240,"lastUpdatePostDateStruct":241,"startDateStruct":243,"completionDateStruct":245,"leadSponsor":247,"locationsCount":4},"100508232","salivary-minerals-in-patients-with-peri-implantitis-100508232","NCT05897736","Salivary Minerals in Patients With Peri-implantitis","Analysis of Salivary Minerals Level Variations in Patients With Peri-implantitis","mineral-perio","Inclusion Criteria:\n\n* diagnosed peri-implantitis\n\nExclusion Criteria:\n\n* uncooperative patient\n* younger then 18 years old",{"count":228,"type":21},25,"3 Weeks","Patients included in the study will be recruited after arriving at the Faculty of Dentistry of the University of Zagreb. During the clinical examination, the patient's periodontal status (bleeding during probing, and the depth of the pockets around the implant) and a control x-ray will be taken to check bone loss. Saliva sampling will occur at 3-time points, when establishing the diagnosis of periimplantitis, before the start of therapy, and at the first control after treatment.",[232,28,233,234,27],"Peri-Implantitis and Peri-implant Mucositis","Periimplant Bone Loss","Periimplant Diseases",[236,237,238,239],"salivary minerals","peri-implantitis","peri-implant health","salivary biomarkers","2023-06-01",{"date":242,"type":39},"2023-06-09",{"date":244,"type":21},"2023-10",{"date":246,"type":21},"2026-09",{"name":248,"class":46},"University of Zagreb"]